Is the six-minute walk test correlated with disease control and quality of life in children with asthma?
To evaluate the changes in a 6-min walk test (6MWT) and quality of life (QoL) before and after asthma control is achieved in children. A 6MWT is used in the determination of disease severity in many chronic childhood diseases. Materials and methods: Thirty-six asthmatic children, aged 6 to 15 years, were enrolled before asthma control was achieved. Disease severity parameters during the previous 3 months were recorded. All of the children completed an asthma control questionnaire (ACQ) and received a symptom score; a 6MWT was performed during enrollment and 1 month later, when asthma control was achieved. Results: The initial and follow-up mean 6MWT distances were 500.2 ± 139.1 and 577.8 ± 147.9 m, respectively (P < 0.001). The 6MWT distances and ACQ scores were significantly correlated initially (rho = -0.35, P = 0.04). The 6MWT distance was not correlated with clinical parameters (P > 0.05 for all). The initial ACQ score was significantly correlated with the symptom score and duration of asthma (rho = 0.62 vs. rho = -0.37). Conclusion: A 6MWT may be used in the functional assessment of children with uncontrolled asthma; it correlates with ACQ scores. The absence of a correlation between the 6MWT and patient-reported symptom severity or other clinical parameters may indicate the necessity to include a functional assessment into the clinical evaluation as well as QoL measures.
Is the six-minute walk test correlated with disease control and quality of life in children with asthma?
To evaluate the changes in a 6-min walk test (6MWT) and quality of life (QoL) before and after asthma control is achieved in children. A 6MWT is used in the determination of disease severity in many chronic childhood diseases. Materials and methods: Thirty-six asthmatic children, aged 6 to 15 years, were enrolled before asthma control was achieved. Disease severity parameters during the previous 3 months were recorded. All of the children completed an asthma control questionnaire (ACQ) and received a symptom score; a 6MWT was performed during enrollment and 1 month later, when asthma control was achieved. Results: The initial and follow-up mean 6MWT distances were 500.2 ± 139.1 and 577.8 ± 147.9 m, respectively (P < 0.001). The 6MWT distances and ACQ scores were significantly correlated initially (rho = -0.35, P = 0.04). The 6MWT distance was not correlated with clinical parameters (P > 0.05 for all). The initial ACQ score was significantly correlated with the symptom score and duration of asthma (rho = 0.62 vs. rho = -0.37). Conclusion: A 6MWT may be used in the functional assessment of children with uncontrolled asthma; it correlates with ACQ scores. The absence of a correlation between the 6MWT and patient-reported symptom severity or other clinical parameters may indicate the necessity to include a functional assessment into the clinical evaluation as well as QoL measures.
___
- Mancuso CA, Choi TN, Westermann H, Briggs WM, Wenderoth S, Charlson ME. Measuring physical activity in asthma patients: two-minute walk test, repeated chair rise test, and self-reported energy expenditure. J Asthma 2007; 44: 333- 40.
- Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fi brotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 1150-7. 3. Cote CG, Casanova C, Marín JM, Lopez MV, Pinto-Plata V, de Oca MM et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 2008; 31: 571-8.
- Nixon PA, Joswiak ML, Fricker FJ. A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996; 129: 362-6.
- Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger. GINA; 2009. Available at http://www.ginasthma.org/uploads/ users/fi les/GINA_Under5_2009_CorxAug11.pdf.
- Quittner AL, Modi A, Cruz I. Systematic review of health- related quality of life measures for children with respiratory conditions. Paediatr Respir Rev 2008; 9: 220-32.
- Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-7.
- Juniper EF, Svensson K, Mörk AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-8.
- Yuksel H, Sogut A, Yilmaz O, Demet M, Ergin D, Kirmaz C. Evaluation of sleep quality and anxiety-depression parameters in asthmatic children and their mothers. Respir Med 2007; 101: 2550-4.
- Strange G, Keogh AM, Williams TJ, Wlodarczyk J, McNeil KD, Gabbay E. Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6-minute walk distance and quality of life. Respirology 2008; 13: 674-82.
- Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small diff erences in functional status: the six- minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-82.
- Yuksel H, Yilmaz O, Sogut A, Ertan P, Onur E. Correlation of quality of life with clinical parameters and eosinophilic cation protein levels in children with allergic rhinoconjunctivitis. Int Arch Allergy and Immunol 2009; 148: 18-22.
- Brown CD, Benditt JO, Sciurba FC, Lee SM, Criner GJ, Mosenifar Z et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD 2008; 5: 117-24.
- Lee AL, Button BM, Ellis S, Stirling R, Wilson JW, Holland AE et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med 2009; 103: 780-5.
- Mak VH, Bugler JR, Roberts CM, Spiro SG. Eff ect of arterial oxygen desaturation on six minute walk distance, perceived eff ort, and perceived breathlessness in patients with airfl ow limitation. Th orax 1993; 48: 33-8.
- Chetta A, Pisi G, Zanini A, Foresi A, Grzincich GL, Aiello M et al. Six-minute walking test in cystic fi brosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 2001; 95: 986-91.